Outpatient therapy with gemcitabine and docetaxel for gallbladder, biliary, and cholangio-carcinomas
Outpatient therapy with gemcitabine and docetaxel for gallbladder, biliary, and cholangio-carcinomas
复制标题
DOI：
10.1023/a:1016209901417
复制
发表时间：
2002-08-01
影响因子：
3.4
通讯作者：
Ridwelski, K
中科院分区：
文献类型：
--
作者：
Kuhn, R;Hribaschek, A;Ridwelski, K
目的.胆管癌患者的预后很差。诊断往往发生在晚期，当根治性切除是不可能的。我们联合吉西他滨和多西他赛优化姑息治疗胆囊癌，胆管癌和胆管癌患者的门诊基础上。经组织学证实的胆管癌患者和WHO体能状态
Purpose. The prognosis of patients with biliary tree carcinomas is very poor. The diagnosis often occurs at an advanced stage, when curative resection is not possible. We combined gemcitabine and docetaxel to optimize the palliative therapy for patients with gallbladder, biliary, and cholangio-carcinomas on an outpatient basis.Patients and methods. Patients with histologically proven biliary tree carcinomas and a WHO performance status